Drug

Contezolid clinical trials

studies test it: 8
open now: 6
in phase 3: 2
first study started: 2015

How each study uses contezolid is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the contezolid studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Approvals

The first approval found in each region, with its record

United States: Not in FDA's approval records
European Union: Not in EMA's list of EU-wide authorisations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Contezolid: 6

Development codes

MRX-I: 1

Studies by the year they started

8 studies that test it; most in 2024 (2)

Studies that test contezolid, by start year
Year	Studies
2015	1
2022	1
2023	1
2024	2
2025	2
2026	1

By phase

A phase 1/2 study counts in both.

Phase 1: 2
Phase 2: 4
Phase 3: 2
Phase 4: 2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Tuberculosis, Pulmonary: 1
Bacterial Infections: 1
Mycobacterium Infections, Nontuberculous: 1
Tuberculosis, Meningeal: 1
Tuberculosis: 1

Who runs them

Industry 2 · Other 6

Beijing Chest Hospital (4) · MicuRx (2) · Bin Cao (2)

Often tested with

Tested in the same studies.

Contezolid acefosamil (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3, 1 in phase 3

Studies that test contezolid, phase 3 first.

Jun 2027Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)Phase 3 · MicuRx
Dec 2026Clinical Study on the Early Bactericidal Activity of Contezolid Against Mycobacterium Abscessus DiseasePhase 2 · Beijing Chest Hospital
Jul 2027Short-term Bactericidal Effect of Contezolid in MAC-PDPhase 4 · Bin Cao

Studies

Open first, then newest update. How each study uses contezolid is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 8

Codes

What other systems call contezolid · ClinicalTrials.gg INT000045

MeSH (NLM) C000590780contezolidOne source NLM
UNII (FDA) B669M62ELPCONTEZOLIDConfirmed FDA, NLM, Wikidata
Wikidata Q27274420contezolidConfirmed FDA, NLM, Wikidata
NCI Thesaurus C171693ContezolidOne source FDA
DrugBank DB12796One source Wikidata

System	Code	Name there	Checked by
MeSH (NLM)	C000590780	contezolid	One source NLM
UNII (FDA)	B669M62ELP	CONTEZOLID	Confirmed FDA, NLM, Wikidata
Wikidata	Q27274420	contezolid	Confirmed FDA, NLM, Wikidata
NCI Thesaurus	C171693	Contezolid	One source FDA
DrugBank	DB12796	—	One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.